Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Immuron Ltd ADR
(NQ:
IMRN
)
2.600
UNCHANGED
Streaming Delayed Price
Updated: 2:48 PM EDT, Sep 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Immuron Ltd ADR
< Previous
1
2
3
4
5
Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 08, 2023
Via
Benzinga
Why Is Tupperware Brands (TUP) Stock Down 8% Today?
May 08, 2023
Tupperware Brands (TUP) stock is taking a beating on Monday after the company said it's exploring strategic alternatives.
Via
InvestorPlace
Why Is Aptorum (APM) Stock Down 16% Today?
May 08, 2023
Aptorum (APM) stock is falling on Monday after the biopharmaceutical company received a delisting notice from the Nasdaq.
Via
InvestorPlace
Why Bellicum Pharmaceuticals Shares Are Trading Higher By 105%; Here Are 20 Stocks Moving Premarket
May 08, 2023
Gainers Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) gained 105.2% to $0.8001 in pre-market trading. Bellicum Pharmaceuticals 13D filing showed Baker Bros. Advisors reported a 19.99% active stake in...
Via
Benzinga
Why Is Immuron (IMRN) Stock Up 67% Today?
May 08, 2023
Immuron (IMRN) stock is gaining on Monday thanks to an update from the Food and Drug Administration (FDA) on a clinical hold.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
May 08, 2023
Pre-market stock movers are a hot topic on Monday as we dive into the biggest winners and losers traders need to know about this morning!
Via
InvestorPlace
Immuron Announces FDA Removed Clinical Hold on New Campylobacter ETEC Therapeutic Paves way for Clinical Trial Initiation
May 08, 2023
From
Immuron Limited
Via
GlobeNewswire
Immuron CEO, Steven Lydeamore to present at Coffee Microcaps
May 02, 2023
From
Immuron Limited
Via
GlobeNewswire
Why NETGEAR Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 27, 2023
Gainers Evelo Biosciences, Inc. (NASDAQ: EVLO) jumped 147.9% to $0.2479. Evelo Biosciences shares dropped 33% on Wednesday after the company announced top-line data from the fourth cohort of its...
Via
Benzinga
Immuron Q3 FY23 Business Update Presentation
April 19, 2023
From
Immuron Limited
Via
GlobeNewswire
Q3 FY23 Business Update Webinar Notification
April 11, 2023
From
Immuron Limited
Via
GlobeNewswire
Immuron Q3 Sales reach 150% of 1H Sales
April 06, 2023
From
Immuron Limited
Via
GlobeNewswire
Immuron CEO, Steven Lydeamore to host an investor webinar
February 15, 2023
From
Immuron Limited
Via
GlobeNewswire
Immuron US DoD Naval Medical Research Center responds to FDA Clinical Hold for New Campylobacter ETEC Therapeutic
January 25, 2023
From
Immuron Limited
Via
GlobeNewswire
US Department of Defense Uniformed Services University Clinical Evaluation of Travelan™ Achieves 150 Recruitment Milestone
January 18, 2023
From
Immuron Limited
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 17, 2023
Via
Benzinga
Immuron Receives European Patent on Drug Composition to Treat Clostridioides difficile Associated Disease
January 17, 2023
From
Immuron Limited
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 26, 2022
Via
Benzinga
Dow Rises 150 Points; Mission Produce Shares Slide
December 23, 2022
U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 150 points on Friday.
Via
Benzinga
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
December 23, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 23, 2022
Via
Benzinga
Dow Surges Over 100 Points; Crude Oil Rises Sharply
December 23, 2022
U.S. stocks traded mostly higher midway through trading, with the Dow Jones gaining over 100 points on Friday.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 23, 2022
Via
Benzinga
Why DBV Technologies Shares Are Trading Higher By 38%; Here Are 26 Stocks Moving Premarket
December 23, 2022
Gainers Expion360 Inc. (NASDAQ: XPON) shares rose 152% to $2.47 in pre-market trading. Expion360 been selected as the exclusive supplier of high-energy lithium ion batteries for an overland trailer...
Via
Benzinga
Immuron Receives FDA Approval for Travelan IND Application
December 23, 2022
From
Immuron Limited
Via
GlobeNewswire
Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday's Mid-Day Session
December 22, 2022
Gainers Core Scientific, Inc. (NASDAQ: CORZ) shares jumped 188% to $0.1471. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 22, 2022
Via
Benzinga
Immuron Submits IND Application To FDA for Travelan
December 05, 2022
From
Immuron Limited
Via
GlobeNewswire
Immuron completes strategic investment in leading gut health biotech Ateria Health
November 16, 2022
From
Immuron Limited
Via
GlobeNewswire
Immuron CEO, Steven Lydeamore to present at AusBioInvest
October 26, 2022
From
Immuron Limited
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.